COMPARAÇÃO DE TRATAMENTOS MEDICAMENTOSOS EM PACIENTES INTERNADOS COM COVID19

This systematic review aims to compare the drugs used for the treatment of COVID-19 in diagnosed and hospitalized patients. The search in the databases generated 97 references, which after the selection and eligibility process, 4 systematic reviews (SR) were selected and used in this narrative synthesis where their data were extracted. The AMSTAR 2 tool was used in the evaluation of methodological quality. The options were grouped according to the adopted interventions: Tocilizumab, Vitamin D, and Atorvastatin. It is concluded that the study has limitations in its methodology, and the results should be analyzed with caution. The presented options need to describe the standard treatment used. Tocilizumab appears to be the best choice in concurrent use with standard treatment.Esta revisão sistemática tem por objetivo comparar os medicamentos utilizados para tratamento da covid19 em pacientes diagnosticados com a doença e internados. A busca nas bases e dados gerou 97 referências, que após o processo de seleção e elegibilidade, foram selecionadas 4 revisões sistemáticas (RS) utilizadas nesta síntese narrativa onde seus dados foram extraídos. A ferramenta AMSTAR 2 foi utilizada na avaliação da qualidade metodológica. As opções foram agrupadas de acordo com as intervenções adotadas: Tociluzumabe, vitamina D e Atorvastatina. Conclui-se que o estudo possui limitações em sua metodologia, devendo os resultados serem analisados com prudência. As opções apresentadas necessitam descrever o tratamento padrão utilizado. O tociluzumabe se mostra a melhor escolha em uso concomitante com o tratamento padrão

Oral health policies and decision-making process in Brazil, Colombia and Chile

Abstract Public health policies are crucial for the well-being of the general population; however, the health systems of developed countries still do not include oral health in its system. Thus, it is necessary to understand the process of decision-making in oral health policies to create opportunities for countries to achieve an overall positive health outcome, including oral health. This study aimed to identify the factors influencing the inclusion of oral health on the political agenda in Brazil, Colombia, and Chile. The study sample involved decision-makers at political, technical, and academic levels. The extracted data were analyzed using the software Maxqda® and Kingdon´s theoretical model; defining interactive variables that produce a “window of opportunity” to define the agenda and the insertion of theme in formulating public policies. The decision-making process regarding oral health is influenced by many factors like the need to improve the overall oral health of the population, identified through national epidemiological studies, and the importance of individuals in positions involving political decision-making, who advocate for oral health. Strategies were developed in partnership with the academy that focused on the health rights of the population provided by law; territorial and national programs were also developed. The inclusion and creation of oral health policies depend on actors who advocate for thematic and scientific evidence to support decision-making. A close relationship between academia and stakeholders and knowledge translation is important for the development of public policies that can be effective for health systems